Abstract
Seroprevalence of HHV-8 has been studied in Malaysia, India, Sri Lanka, Thailand, Trinidad, Jamaica and the USA, in both healthy individuals and those infected with HIV. Seroprevalence was found to be low in these countries in both the healthy and the HIV-infected populations. This correlates with the fact that hardly any AIDS-related Kaposi’s sarcoma has been reported in these countries. In contrast, the African countries of Ghana, Uganda and Zambia showed high seroprevalences in both healthy and HIV-infected populations. This suggests that human herpes virus-8 (HHV-8) may be either a recently introduced virus or one that has extremely low infectivity. Nasopharyngeal and oral carcinoma patients from Malaysia, Hong Kong and Sri Lanka who have very high EBV titres show that only 3/82 (3.7%) have antibody to HHV-8, demonstrating that there is little, if any, cross-reactivity between antibodies to these two gamma viruses.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bestetti, G, Renon, G, Mauclere, P, Ruffie, A, Mbopi Keou, FX, Emo, D, Parravicini, C, Corbellino, M, de Thé, G & Gessain, A (1998) High seroprevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon. AIDS 12: 541–543.
Bhoopat, L, Thampraser, K, Chalwan, B, Attasiri, C, Vithayasal, P & Chaimongkoi, B (1994) Histopathologic spectrum of AIDS associated lesions in Maharaj Nakon Chaing Mai Hospital. Asian Pac J Immunol 12: 95–104.
Boshoff, C & Weiss, R (1998) Kaposi’s sarcoma-associated herpesvirus. Adv Cancer Biol Res 75: 57–86.
Bourboulia, D, Whitby, D, Boshoff, C, Newton, R, Beral, V, Carrara, H, Lane, A & Sitas, F (1998) Serological evidence for vertical transmission of KSHV/HHV-8 in healthy South African children. J Am Med Assoc 280: 31–32.
Chang, Y & Moore, PS (1996) Kaposi’s sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 5: 215–222.
Chang, Y, Cesarman, E, Pessin, MS, Lee, F, Culpepper, J, Knowles, DM & Moore, PS (1994) Identification of herpes-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 265: 1865–1869.
Chatlynne, LG, Lapps, W, Handy, M, Huang, YQ, Masood, R, Hamilton, AS, Said, JW, Koeffler, HP, Kaplan, MH, Friedman-Kien, A, Gill, PS, Whitman, JE & Ablashi, DV (1998) Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi’s sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 92: 53–58.
Davis, DA, Humphrey, RW, Newcomb, FM, O’Brien, TR, Goedert, JJ, Strauss, SF & Yarchoan, R (1997) Detection of serum antibodies to Kaposi’s sarcoma-associated herpesvirus specific peptides. J Infect Dis 175: 1971–1979.
Ganem, D (1996) Human herpesvirus 8 and the biology of Kaposi’s sarcoma. Semin Virol 7: 325–332.
Gao, SJ, Kingsley, L, Li, M, Zheng, W, Parravinci, C, Zeigler, J, Newton, R, Rinaldo, CR, Saah, A, Phair, J, Detels, R, Chang, Y & Moore, P (1996a) KSHV antibodies among Americans, Italians, and Ugandans with and without Kaposi’s sarcoma. Nat Med 2: 925–928.
Gao, SJ, Kingsley, L, Hoover, DR, Spira, TJ, Rinaldo, CR, Saah, A, Phair, J, Detels, R, Parry, P, Chang, Y & Moore, PS (1996b) Seroconversion to antibodies against Kaposi’s sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi’s sarcoma. N Engl J Med 335: 233–241.
Gessain, A, Mauclère, P, Van Beveren, M, Plancoulaine, S, Ayouba, A, Essame-Oyono, J-L, Martin, PMV & de Thé, G (1999) Human herpesvirus-8 primary infection occurs during childhood in Cameroon, Central Africa. Intl J Cancer 81: 189–192.
Gill, PS (1998). Personal Communication. University of Southern California, Los Angeles, CA, USA
IARC Monographs Volume, 70 (1997). On Epstein-Barr Virus and Human Herpesvirus-8. Published by World Health Organization Intl Agency for Res on Cancer, 1997
Jensen, F (1998). Personal Communication. Immune Response Corporation, Carlsbad, CA, USA
Kedes, DH, Operskalski, E, Busch, M, Kohn, R, Flood, J & Ganem, D (1996) The seroepidemiology of human herpesvirus-8 (Kaposi’s sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2: 918–924.
Lin, SF, Sun, R, Heston, L, Granville, L, Shedd, D, Haglaund, K, Rigsby, M & Miller, G (1997) Identification, expression, and immunogenicity of Kaposi’s sarcoma-associated herpesvirus-encoded small viral capsid antigen. J Virol 71: 3069–3076.
Luppi, MD, Whitby, D, Barozzi, P, Boshoff, C, Weiss, RW, Cucci, F & Torelli, G (1998) Age- and sex-specific seroprevalence of human herpesvirus 8 in Jamaica – response. J Natl Cancer Inst 90: 1103–1104.
Manns, A, Strickler, HD, Hanchard, B, Manassaram, DM, Waters, D & Ablashi, DV (1998) Age- and sex-specific seroprevalence of human herpesvirus-8 in Jamaica. J Natl Cancer Inst 90: 1102–1103.
Martin, JN, Ganem, DE, Osmond, DH, Page-Schafer, KA, Macrae, D & Kedes, DH (1998) Sexual transmission and the natural history of human herpesvirus-8 infection. N Engl J Medicine 338: 948–954.
Miller, G, Rigsby, MO, Heston, L, Grogan, E, Sun, R, Metroka, C, Levy, JA, Gao, SJ, Chan, Y & Moore, P (1996) Antibodies to butyrate-inducible antigens of Kaposi’s sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 334: 1292–1297.
Oskenhendler, E, Cazals-Hatem, D, Schulz, TF, Barateau, V, Grollet, L, Sheldon, J, Clauvel, JP, Sigaux, F & Agbalika, F (1998) Transient angiolymphoid hyperplasia and Kaposi’s sarcoma after primary infection with human herpesvirus-8 in a patient with human immunodeficiency virus infection. N Engl J Med 338: 1585–1590.
Raab, MS, Albrecht, JC, Birkman, A, Yaguboglu, S, Lang, D, Fleckenstein, B & Neipel, F (1998) The immunogenic glycoprotein gp35–37 of human herpesvirus-8 is encoded by open reading frame K8.1. J Virol 72: 6725–6731.
Schulz, TF (1998) Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 79: 1573–1591.
Simpson, GR, Schulz, TF, Whitby, D, Cook, PM, Boshoff, C, Rainbow, L, Howard, MR, Gao, SJ, Bohenzky, RA, Simmonds, P, Lee, C, deRuiter, A, Hatzakism, A, Tedder, RS, Weller, IVD, Weiss, RA & Moore, PS (1996) Prevalence of Kaposi’s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348: 1133–1138.
Sukpanichant, S, Sonakul, D, Plankijagum, A, Wanachiwanawin, W, Veerakul, G, Mahasandana, C, Tanphalchitr, VS & Suvatte, V (1998) Malignant lymphoma in Thailand. Cancer 83: 1197–1204.
Verbeek, W, Frankel, M, Miles, S, Said, J & Koeffler, HP (1998) Seroprevalence of HHV-8 antibodies in HIV-positive homosexual men without Kaposi’s sarcoma and their clinical follow-up. Microbiol Infect Dis 109: 778–783.
Wabinga, HR, Pakin, DM, Wabwire-Mangen, F & Mugerwa, JW (1993) Cancer in Kampala, Uganda in 1989–1991: changes in incidence in the era of AIDS. Intl J Cancer 54: 23–36.
Whitby, D, Luppi, M, Barozzi, P, Boshoff, C, Weiss, RA & Torelli, G (1998) HHV-8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 90: 395–397.
Ziegler, JL (1993) Endemic Kaposi’s sarcoma in Africa and local volcanic soils. Lancet 342: 1348–1351.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ablashi, D., Chatlynne, L., Cooper, H. et al. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 81, 893–897 (1999). https://doi.org/10.1038/sj.bjc.6690782
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690782
This article is cited by
-
Kaposi’s sarcoma-associated herpesvirus related malignancy in India, a rare but emerging member to be considered
VirusDisease (2020)
-
HHV-8 seroprevalence: a global view
Systematic Reviews (2014)